肝细胞癌的流行病学
肝细胞癌是全球癌症负担的重要组成部分,近几十年许多国家发病率上升。乙肝和丙肝病毒目前仍是最重要的全球风险因素,但随新生儿乙肝疫苗接种及慢性感染有效治疗,其重要性可能下降;代谢综合征、肥胖、2型糖尿病和非酒精性脂肪性肝病等代谢风险因素患病率上升,可能共同成为全球肝细胞癌的主要原因。过量饮酒和黄曲霉毒素污染仍是难以控制的危险因素。
要点
- 乙肝和丙肝病毒感染目前仍是肝细胞癌最重要的全球风险因素。
- 新生儿乙肝疫苗接种和慢性乙肝/丙肝的有效治疗可能降低病毒相关肝细胞癌发病率。
- 代谢综合征、肥胖、2型糖尿病和非酒精性脂肪性肝病患病率上升,可能共同成为肝细胞癌主因。
核心结论
- 乙肝和丙肝病毒目前仍是肝细胞癌最重要的全球风险因素,但其重要性预计在未来几年下降。
- 代谢风险因素(代谢综合征、肥胖、2型糖尿病、非酒精性脂肪性肝病)患病率上升,可能共同成为全球肝细胞癌的主要原因。
- 过量饮酒和黄曲霉毒素污染仍是难以控制的肝细胞癌风险因素。
- 除早期诊断和更好治疗外,针对降低肥胖和糖尿病患病率及控制霉菌毒素生长的初级预防同样紧迫。
主要发现
- 近几十年许多国家肝细胞癌发病率上升。
- 肝细胞癌是肝癌的主要组织学类型,占肝癌诊断和死亡的绝大多数。
- 新生儿乙肝疫苗接种的效果已在一些国家的年轻成人中显现,随接种人群年龄增长将更明显。
- 慢性乙肝和丙肝感染的有效治疗应有助于降低病毒相关肝细胞癌发病率。
- 代谢综合征、肥胖、2型糖尿病和非酒精性脂肪性肝病等代谢风险因素的患病率正在增加。
临床怎么用
- 应重视新生儿乙肝疫苗接种和慢性乙肝/丙肝感染的有效治疗以降低病毒相关肝细胞癌风险。
- 需关注代谢综合征、肥胖、2型糖尿病和非酒精性脂肪性肝病等代谢风险因素的防控。
- 应继续控制过量饮酒和黄曲霉毒素污染等难控风险因素。
- 除早期诊断和治疗外,针对肥胖、糖尿病和霉菌毒素的初级预防同样紧迫。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Liver cancer is a major contributor to the worldwide cancer burden. Incidence rates of this disease have increased in many countries in recent decades. As the principal histologic type of liver cancer, hepatocellular carcinoma (HCC) accounts for the great majority of liver cancer diagnoses and deaths. Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain, at present, the most important global risk factors for HCC, but their importance will likely decline in the coming years. The effect of HBV vaccination of newborns, already seen in young adults in some countries, will be more notable as vaccinated cohorts age. In addition, effective treatments for chronic infections with both HBV and HCV should contribute to declines in the rates of viral-associated HCC. Unfortunately, the prevalence of metabolic risk factors for HCC, including metabolic syndrome, obesity, type II diabetes and non-alcoholic fatty liver disease (NAFLD) are increasing and may jointly become the major cause of HCC globally. Excessive alcohol consumption also remains an intractable risk factor, as does aflatoxin contamination of food crops in some parts of the world. While significant efforts in early diagnosis and better treatment are certainly needed for HCC, primary prevention efforts aimed at decreasing the prevalence of obesity and diabetes and controlling mycotoxin growth, are just as urgently required.
引用
- McGlynn KA, Petrick JL, El-Serag HB, et al. Epidemiology of Hepatocellular Carcinoma. Hepatology. 2020. PMID: 32319693. doi:10.1002/hep.31288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。